2 recruiting, 1 not yet recruiting. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 2, Not yet recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow GnP: new trials by email Literature Review of GnP trials Research Report on GnP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma Atebimetinib, GnP, mGnP - Pancreatic Cancer, Pancreatic Cancer Metastatic | Phase 3 | Recruiting | Immuneering Corporation | 570 | 2026-06-05 | 2026-11-06 |
| A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2) GnP, SBRT, Serplulimab - PDAC - Pancreatic Ductal Adenocarcinoma | Phase 3 | Not yet recruiting | West China Hospital | 198 | 2026-02-01 | 2026-01-13 |
| Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP GS, GnP - Pancreatic Adenocarcinoma | Phase 2 / Phase 3 | Recruiting | Kochi University | 500 | 2019-01-01 | 2022-03-07 |
Neoplasm Metastasis (1) · Pancreatic Neoplasms (1)
Immuneering Corporation (1) · Kochi University (1) · West China Hospital (1)
Australia (1) · Georgia (1) · Germany (1) · Hungary (1) · Japan (1) · Poland (1) · Romania (1) · Spain (1) · United Kingdom (1) · United States (1)